GleamWall
中文EN

PETS PETMED EXPRESS INC

Retail-Drug Stores and Proprietary Stores · Nasdaq · SEC CIK 1040130 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-17.4%
TTM net income YoY50.6%
TTM EPS YoY51.1%
Revenue 3-yr CAGR-15.2%
Net income 3-yr CAGR—

Margins

Gross margin27.8%
Operating margin-18.0%
Net margin-17.0%
FCF margin-15.4%
EBITDA margin-12.3%

Returns

ROE-90.8%
ROA-34.1%
ROIC (approx.)-366.8%
Asset turnover2.01x

Leverage & solvency

Liabilities / assets71.6%
Debt / equity0.00x
Current ratio0.60x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.83x
Accruals ratio-5.6%
Payout ratio—
Capex / revenue1.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q22026-09-302027Q12026-06-302026Q4*2026-03-312026Q32025-12-312026Q22025-09-302026Q12025-06-302025Q4*2025-03-312025Q32024-12-31
Income statement
Revenue$35.77M$41.02M$42.82M$40.66M$44.36M$51.18M$46.47M$51.96M
Cost of revenue$25.97M$29.68M——$31.95M$36.78M$27.52M$35.83M
Gross profit$9.80M$11.33M$13.94M$9.46M$12.41M$14.40M$18.95M$16.13M
SG&A expense$11.97M$11.20M$11.41M$12.19M$14.18M$12.95M$12.49M$10.79M
Operating income-$6.42M-$6.23M-$5.69M-$10.47M-$8.38M-$34.13M-$6.02M-$450,000
Interest expense$200,000$400,000—$400,000$600,000$500,000—$400,000
Pretax income-$6.42M-$6.13M-$4.16M-$10.54M-$8.51M-$34.14M-$5.98M-$242,000
Income tax$14,000$13,000-$102,000$11,000$9,000$9,000$5.66M$465,000
Net income-$6.43M-$6.14M-$4.06M-$10.55M-$8.52M-$34.15M-$11.64M-$707,000
EBITDA-$4.24M-$4.08M-$3.27M-$8.07M-$6.10M-$31.85M-$3.95M$1.14M
EPS (basic)-0.31-0.28—-0.50-0.41-1.65—-0.03
EPS (diluted)-0.31-0.28—-0.50-0.41-1.65—-0.03
Dividends declared per share——————0.000.00
Weighted avg. shares (diluted)21.07M21.68M—21.01M20.89M20.76M—20.63M
Balance sheet
Cash & equivalents$11.42M$13.08M$21.41M$26.91M$36.10M$41.13M$54.72M$50.10M
Receivables$1.37M$1.71M$1.91M$1.56M$1.97M$1.60M$2.32M$2.26M
Inventory$6.30M$8.47M$13.61M$12.21M$14.77M$18.36M$16.20M$11.79M
Current assets$25.34M$27.61M$43.56M$48.51M$59.45M$67.89M$78.87M$68.38M
PP&E, net$23.47M$25.21M$26.33M$27.55M$28.34M$28.84M$28.86M$28.43M
Goodwill——$0$0$0$0$26.66M$26.66M
Intangibles$5.01M$5.25M$5.49M$5.98M$6.47M$6.96M$8.05M$9.73M
Total assets$59.40M$63.76M$81.19M$87.97M$100.30M$109.84M$148.70M$144.79M
Current liabilities$42.37M$40.60M$52.03M$54.77M$56.68M$57.62M$62.77M$47.96M
Total liabilities$42.54M$40.77M$52.25M$55.20M$57.24M$58.29M$63.57M$48.61M
Shareholders' equity$16.86M$22.99M$28.94M$32.77M$43.06M$51.55M$85.13M$96.18M
Shares outstanding22.13M21.68M21.39M21.38M21.02M20.84M20.66M20.66M
Cash flow statement
Operating cash flow-$1.06M-$7.69M-$4.74M-$9.21M-$2.17M-$12.27M$7.01M-$1.17M
Capital expenditure$586,000$641,000$720,000-$21,000$2.62M$1.29M$2.39M$777,000
Free cash flow-$1.64M-$8.33M-$5.46M-$9.18M-$4.80M-$13.56M$4.62M-$1.94M
Investing cash flow-$586,000-$641,000-$720,000$21,000-$2.62M-$1.29M-$2.39M-$777,000
Financing cash flow-$18,000-$5,000-$38,000$0-$231,000-$30,000-$5,000-$1,000
Depreciation & amortization$2.18M$2.15M$2.43M$2.40M$2.28M$2.28M$2.07M$1.59M
Stock-based compensation$326,000$198,000$272,000$300,000$200,000$591,000$593,000$500,000
Dividends paid$0$0-$3,000$1,000$22,000$1,000$5,000$1,000

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.